Reblozyl
News/ News/ Sales and Marketing
Rumour mill says Acceleron is speeding towards $11bn sale
Phil Taylor
Acceleron, Bristol-Myers Squibb, M&A, Reblozyl
0 Comment
X
Rumour mill says Acceleron is speeding towards $11bn sale
https://pharmaphorum.com/news/rumour-mill-says-acceleron-is-speeding-towards-11bn-sale/
EHA21: Study raises BMS’ hopes for Reblozyl in less severe disease
Phil Taylor
Acceleron, beta thalassaemia, Bristol-Myers Squibb, EHA 2021, luspatercept, myelodysplastic syndrome, Reblozyl
0 Comment
X
EHA21: Study raises BMS’ hopes for Reblozyl in less severe disease
https://pharmaphorum.com/news/eha21-study-raises-bms-hopes-for-reblozyl-in-less-severe-patients/